Global Ultrasound Biopsy Needles Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Ultrasound Biopsy Needles market size was valued at US$ 797 million in 2025 and is forecast to a readjusted size of US$ 1542 million by 2032 with a CAGR of 10.0% during review period.
Ultrasound biopsy needles are minimally invasive medical devices used under real-time ultrasound, endoscopic ultrasound, or endobronchial ultrasound guidance to collect cells or tissue samples from suspicious lesions, masses, lymph nodes, or organs. These devices are designed for fine-needle aspiration, fine-needle biopsy, core tissue acquisition, or vacuum-assisted biopsy, supporting cytological, histological, molecular, and oncological diagnosis.Ultrasound biopsy needles are usually sold by unit or by set. Pricing varies significantly by product type, including percutaneous core biopsy needles, EUS-FNA/FNB needles, EBUS-TBNA needles and vacuum-assisted biopsy needles. Based on public channel prices and industry research estimates, standard disposable core biopsy needles are generally priced at around USD 20–60/unit; domestic or basic EUS-FNA needles are around USD 80–150/unit; imported EUS-FNA/FNB or EBUS-TBNA needles are commonly priced at USD 150–350/unit; and vacuum-assisted breast biopsy needles may reach USD 300–800/unit or above due to their more complex structure and system compatibility requirements. Actual hospital procurement prices are affected by brand, regulatory approval, purchase volume, tender policy and distributor margins.
The upstream segment mainly includes medical-grade stainless steel tubing, nitinol alloy, needle-tip cutting materials, plastic handles, spring components, puncture sheaths, echogenic coatings, sterile packaging materials and precision processing equipment. The midstream segment covers tube drawing, needle-tip grinding, laser marking, echogenic treatment, handle assembly, sterile packaging, ethylene oxide sterilization and quality inspection. Key barriers include tip sharpness, sampling notch design, smooth needle advancement, ultrasound visibility and batch consistency. Downstream applications include digestive endoscopy, respiratory intervention, breast surgery, thyroid biopsy, liver biopsy, lymph-node biopsy, urology and oncology tissue sampling. End users mainly include hospital endoscopy centers, interventional radiology departments, pathology centers and third-party medical institutions.
Market Drivers
Rising Demand for Early Tumor Screening and Precision Diagnosis
Ultrasound biopsy needles are primarily required for histopathological confirmation of tumors, nodules, lymph nodes and solid lesions. With surging screening volumes for breast cancer, thyroid nodules, liver tumors, pancreatic lesions, lung cancer and gastrointestinal tumors, clinical demand for minimally invasive, real-time image-guided biopsy tools enabling rapid tissue sampling keeps growing. Data from WHO/IARC indicates approximately 20 million new cancer cases worldwide in 2022, and this large diagnostic base directly fuels the expansion of the biopsy needle consumables market.
Upgrading Substitution of High-End Products such as EUS-FNB
In digestive endoscopy and respiratory intervention, EUS-FNA, EUS-FNB and EBUS-TBNA have become vital sampling tools for pancreatic masses, mediastinal lesions, submucosal gastrointestinal lesions and lymph nodes. Compared with conventional fine-needle aspiration needles, FNB needles excel in retrieving intact tissue strips, preserving pathological architecture and supporting molecular testing. Guidelines issued by the American Society for Gastrointestinal Endoscopy (ASGE) recommend FNB needles as the first choice for EUS sampling of solid pancreatic masses, which will drive higher unit prices and penetration rates of high-end biopsy needles.
Accelerated Adoption of Minimally Invasive Diagnosis & Outpatient-Based Workflows
Ultrasound-guided biopsy features real-time localization, minimal trauma, fast patient recovery and relatively manageable operating costs, making it suitable for breast, thyroid, liver, superficial lymph node procedures and partial endoscopic interventions. Hospitals aim to boost sampling efficiency and reduce repeated punctures and inadequate specimens through standardized needles, vacuum-assisted systems and designs with enhanced ultrasound visibility. Next-generation breast biopsy systems are evolving toward compatibility with multi-modal imaging platforms, streamlined workflows and improved operational efficiency.
Market Challenges
High Barriers to Registration, Certification and Clinical Access
Ultrasound biopsy needles are invasive medical consumables that penetrate human tissue, with stringent requirements for sterility, safety, needle tip sharpness, sampling consistency, ultrasound visibility and batch-to-batch uniformity. According to public FDA records, EUS biopsy needle products from Cook, Boston Scientific and other manufacturers must complete corresponding 510(k) submissions or regulatory classification reviews. For new market entrants, product registration, clinical trials, quality system validation and hospital adoption cycles significantly delay commercialization.
Intense Price Pressure and Shrinking Channel Margins
Biopsy needles are high-volume single-use consumables. Hospital procurement prioritizes pricing, stable supply and after-sales support. In markets including China, volume-based centralized procurement for medical consumables continues to streamline distribution layers and squeeze end-market prices, imposing downward cost pressure on both imported and domestic brands. Enterprises lacking large-scale manufacturing capacity, comprehensive registration approvals or direct sales networks face risks of eroded gross profit margins and shrinking market share amid shifting tender policies.
Product Homogenization and Competition from Alternative Technologies
Basic core biopsy needles and standard FNA needles boast mature structures, triggering price competition as domestic manufacturers enter the market. While high-end segments see upgraded offerings including FNB needles, vacuum-assisted biopsy needles and sonographically visible needles, competing sampling technologies vie for market share based on applicable indications and cost trade-offs. For instance, clinical studies reveal discrepancies in diagnostic yield, tissue volume and procedural efficiency across various EUS sampling modalities; hospitals select products according to lesion types, physician preferences and economic considerations.
This report is a detailed and comprehensive analysis for global Ultrasound Biopsy Needles market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ultrasound Biopsy Needles market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ultrasound Biopsy Needles market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ultrasound Biopsy Needles market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ultrasound Biopsy Needles market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ultrasound Biopsy Needles
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ultrasound Biopsy Needles market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Covidien, Cook Medical, Olympus, CONMED, Medi-Globe GmbH, Micro-Tech China, Shanghai Nuobang Bio-tech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ultrasound Biopsy Needles market is split by Type and by End User. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
EUS-FNA
EUS-FNB
Others(EBUS)
Market segment by Sampling Method
Fine Needle Aspiration Needles
Fine Needle Biopsy Needles
Core Biopsy Needles
Vacuum-assisted Biopsy Needles
Market segment by Product Structure
Standard Biopsy Needle
Automatic / Semi-automatic Biopsy Needle
Echogenic Biopsy Needle
Advanced Tissue Acquisition Needle
Market segment by End User
Public Hospitals
Private Hospitals
Major players covered
Boston Scientific
Covidien
Cook Medical
Olympus
CONMED
Medi-Globe GmbH
Micro-Tech China
Shanghai Nuobang Bio-tech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ultrasound Biopsy Needles product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ultrasound Biopsy Needles, with price, sales quantity, revenue, and global market share of Ultrasound Biopsy Needles from 2021 to 2026.
Chapter 3, the Ultrasound Biopsy Needles competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ultrasound Biopsy Needles breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by End User, with sales market share and growth rate by Type, by End User, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ultrasound Biopsy Needles market forecast, by regions, by Type, and by End User, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ultrasound Biopsy Needles.
Chapter 14 and 15, to describe Ultrasound Biopsy Needles sales channel, distributors, customers, research findings and conclusion.